Quick Answer
Genprex, Inc. reported Cash and Equivalents of $7.83 million for fiscal year 2025.
Genprex, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $7.83M | +388.9% |
| 2024 | $1.60M | -76.2% |
| 2023 | $6.74M | -67.8% |
| 2022 | $20.95M | +12894.7% |
| 2017 | $161.3K | -89.9% |
| 2016 | $1.60M | +584.1% |
| 2015 | $234.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.10M | -25.9% | -18.1% |
| June 30, 2025 | $1.35M | -45.2% | -61.2% |
| March 31, 2025 | $3.47M | -57.8% | +116.5% |
| December 31, 2024 | $1.60M | -76.2% | +7.6% |
| September 30, 2024 | $1.49M | -87.3% | -39.5% |
| June 30, 2024 | $2.46M | -75.3% | -70.1% |
| March 31, 2024 | $8.22M | -54.6% | +22.0% |
| December 31, 2023 | $6.74M | -67.8% | -42.5% |
- Genprex, Inc. showed an increase of +388.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2015–2025 period, Genprex, Inc.’s cash and equivalents has grown by 3243.4% (from $234.2 thousand to $7.83 million).
- The most recent figure is from Genprex, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: